CHF COPD Sip Feed Anabolic Response
Completed · Not applicable
Conditions studied: Pulmonary Disease, Chronic Obstructive, Congestive Heart Failure
In brief
Weight loss commonly occurs in patients with chronic heart failure (CHF) and chronic obstructive pulmonary disorder (COPD), negatively influencing their quality of life, treatment response and survival. Loss of muscle protein is generally a central component of weight loss in CHF and COPD patients, but patients also have reductions in fat mass and bone density, independent of the severity of the disease state. The purpose of this study is to provide detailed insight in disease related gut function by obtaining information on gut permeability, digestion and absorption of glucose, fat and protein in CHF and COPD patients compared to matched healthy controls. This will provide required information that is necessary to implement new strategies to develop optimal nutritional regimen in CHF and COPD.
Key facts
- Study ID
- NCT02770092
- Run by
- Texas A&M University
- People needed
- 90
- Starts
- 2016-02-10
- Expected to finish
- 2018-05-15
- Last updated by the study team
- 2025-10-01
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Texas A&M University-CTRAL — College Station, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.